期刊文献+

免疫调理对脓毒症大鼠中性粒细胞和淋巴细胞亚群的影响 被引量:4

Immunomodulation effect on neutrophil leukocyte and lymphocyte subsets in septic rats
原文传递
导出
摘要 目的研究免疫调理对脓毒症大鼠中性粒细胞和淋巴细胞及其亚群的影响,阐明免疫调理在脓毒症治疗中的作⒚。方法成功制作SD大鼠盲肠结扎穿孔(CLP)脓毒症模型,被分为假手术组、对照组和实验组,各20只。制作脓毒症模型后分别在3、12、24、48h采血待测。检查外周血涂片、白细胞总数、中性粒细胞、淋巴细胞计数和CD4+、CD8+T淋巴细胞亚群。结果实验组白细胞计数和中性粒细胞计数比对照组明显降低,而淋巴细胞计数和CD4+T淋巴细胞水平比对照组明显升高,P<0.05。实验组CD8+T淋巴细胞水平与对照组差异无统计学意义。结论免疫调理可以明显降低脓毒症大鼠白细胞和中性粒细胞,从而减轻炎症反应。免疫调理可以提高脓毒症大鼠淋巴细胞计数和CD4+T淋巴细胞,从而改善免疫功能。 Objective To knowledge the mechanism of immunomodulation, we study immunomodulation effect on neutrophil leukocyte and lymphocyte subsets in septic rat. Methods Cecal ligation-perforation (CLP) rat model were divided into three groups including sham group (n =20), control group(n =20) and experimental group(n=20). Blood collections were made after CLP model in 3, 12, 24, 48 h respectively. Leukocyte, neutrophil leukocyte, lymphocyte counting and CD4^+, CD8^+ T lymphocyte were detected. Results CLP rat as septic model, leukocyte and neutrophil leukocyte in experimental group decreased more significant than that in control group, P 〈 0.05. Lymphocyte in experimental group increased more significant than that in control group, P 〈 0.05. CD4^+T lymphocyte in experimental group increased more significant than that in control group, P 〈 0.05. CD8^+ T lymphocyte had no difference in two groups. Conclusions Immunomodulafion in septic rat can decrease leukocyte and neutrophil leukocyte and alleviate sequential inflammatory reaction. Immunomodulation in septic rat can increase lymphocyte and CD4^+ T lymphocyte and improve immune function as a matter of fact.
出处 《中华普通外科学文献(电子版)》 2009年第5期4-6,共3页 Chinese Archives of General Surgery(Electronic Edition)
基金 中山大学5010计划-SEPSIS系列研究(2007015)
关键词 脓毒症 中性粒细胞 淋巴细胞 T淋巴细胞亚群 免疫调理 Sepsis Neutrophil leukocyte Lymphocyte T lymphocyte subsets Immunomodulation
  • 相关文献

参考文献3

二级参考文献29

  • 1Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care[J]. Crit Care Med,2000,28 (6): 1871 - 1876.
  • 2Van De Wouwer M, Conway EM. Novel functions of thrombomodulin inflammation [J]. Crit Care Med, 2004,32 (5): S254-261.
  • 3Bone RC ,Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [J]. Chest, 1992, 101 (6) :1644 - 1655.
  • 4Theodore EW, William C ,and Jacob HR. Platelet -Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome [J]. Hematology, 2003,2003(2) :497 -518.
  • 5Ballow M. Clinical and investigational considerations for the use of IGIV therapy[J]. Am J Health Syst Pharm, 2005,62( 16 suppl 3) : S12-18.
  • 6Lee M, Gale R, Yap P. Use of intravenous immunoglobulin to prevent or treat infections in persons with immune deficiencies[J]. Annu Rev Med,1999,48(2) :93 - 102.
  • 7Rodriguez A, Neira J, Ceraso D, et al. Effects of high - dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery [J]. Shock, 2005,23 (4) : 298 - 304.
  • 8Gotzsche PC. Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review [J]. Clln Infect Dis, 2004,39 (1): 38-46.
  • 9Angus DC,Linde-Zwinble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29(5):1303-1310.
  • 10No authors listed.American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Crit Care Med,1992,20(6):864-874.

共引文献21

同被引文献49

  • 1陈怀生,文舜康,吴胜楠.脓毒症与凋亡[J].华西医学,2006,21(2):414-415. 被引量:2
  • 2黄顺伟,管向东,陈娟,欧阳彬.创伤性严重脓毒症和多器官功能障碍综合征免疫调理治疗的临床研究和远期评价[J].中国危重病急救医学,2006,18(11):653-656. 被引量:19
  • 3HOTCHKISS R S,KARL I E.The pathophysiology and treatment of sepsis[J].N Engl J Med,2003,348(2):138-150.
  • 4TINSLEY K W,GRAYSON M H,SWANSON P E,et al.Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells[J].J Immunol,2003,171(2):909-914.
  • 5TUGND S,OZCAN P E,AKINCI O,et al.The effects of IgM-enriched immunoglobulin preparation in patients with severe sepsis[J].Crit Care,2002,6(4):357-362.
  • 6MARTIN J M,STAPLETON R D.Omega-3 fatty acids in critical illness[J].Nutr Rev,2010,68(9):531-541.
  • 7MAYER K,GOKORSCH S,FEGBEUTEL C,et al.Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis[J].Am J Respir Crit Care Med,2003,167(10):1321-1328.
  • 8SINGER P,SHAPIRO H,THEILLA M,et al.Anti-inflammatory properties of omega-3 fatty acids in critical illness:novel mechanisms and an integrative perspective[J].Intensive Care Med,2008,34(9):1580-1592.
  • 9TSOU S S,CHIU W C,YEH C L,et al.Effects of omega-3 fatty acids on inflammatory mediators and splenocyte cytokine mRNA expressions in rats with polymicrobial sepsis[J].Nutrition,2008,24(5):484-491.
  • 10Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. AmericanCollege of Chest Physicians/Society of Critical Care Medicine[C]. Chest, 1992, 101(6): 1644-1655.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部